Medy-Tox (XKRX:086900) Marketable Securities : ₩99 Mil (As of Dec. 2023)

View and export this data going back to 2009. Start your Free Trial

What is Medy-Tox Marketable Securities?

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price. Medy-Tox's Marketable Securities for the quarter that ended in Dec. 2023 was ₩99 Mil.

Medy-Tox's annual Marketable Securities declined from Dec. 2021 (₩10,150 Mil) to Dec. 2022 (₩5,520 Mil) and declined from Dec. 2022 (₩5,520 Mil) to Dec. 2023 (₩99 Mil).

Medy-Tox Marketable Securities Historical Data

The historical data trend for Medy-Tox's Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Medy-Tox Marketable Securities Chart

Medy-Tox Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Marketable Securities

Get a 7-Day Free Trial

3,500.00

11,620.72

10,150.10

5,520.31

98.91

Medy-Tox Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Marketable Securities	Get a 7-Day Free Trial															5,520.31	1,500.00	50.00	90.65	98.91

Medy-Tox Marketable Securities Calculation

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.

Medy-Tox (XKRX:086900) Marketable Securities Explanation

Marketable Securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

Please note, GuruFocus' Marketable Securities also includes "Other Short Term Investment".

Medy-Tox Marketable Securities Related Terms

Thank you for viewing the detailed overview of Medy-Tox's Marketable Securities provided by GuruFocus.com. Please click on the following links to see related term pages.

Medy-Tox (XKRX:086900) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Medy-Tox Inc (XKRX:086900) » Definitions » Marketable Securities

Comparable Companies

Traded in Other Exchanges

N/A

Address

641-4, Gak-Ri, Ochang-Eup, Cheongwon, KOR, 363885

Website

http://www.medytox.com

Medy-Tox Inc. is a Korea-based company engaged in the development, manufacture, and marketing of biopharmaceuticals. The company's main product is type-A botulium toxin biopharmaceuticals which are used as remedies for blepharospasms, hemifacial spasms, eye wrinkles, hyperhidrosis diseases and infantile cerebral palsy. The group provides its products under the brand names of Neuronox, Siax and others. It distributes its products within Korean and to overseas markets, such as Japan, China, Russia and Europe, among others.

Medy-Tox (XKRX:086900) Headlines

No Headlines